Search results
Results From The WOW.Com Content Network
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International Nonproprietary Name
WHO definition. A stringent regulatory authority is a regulatory authority which is: a) a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), being the European Commission, the US Food and Drug Administration and the Ministry of Health, Labour and Welfare of Japan also ...
Fluvoxamine was the first SSRI to be approved in Japan (1999). [5] [6] Sertraline received approval in April 2006, having been pending approval for over 15 years. [7] [8] Currently (as of 2017) the three most sold antidepressants in Japan are duloxetine, mirtazapine, and escitalopram (Lexapro). [9]
Drug-related deaths in Japan (2 C, 3 P) Drug policy of Japan (5 P) Japanese drug traffickers (2 P)
It is similar in function to the Food and Drug Administration in the United States, the Medicines and Healthcare products Regulatory Agency in the United Kingdom, the Spanish Agency of Medicines and Medical Devices in Spain or the Food and Drug Administration in the Philippines. The PhMDA has been eCTD compliant at least since December 2017.
Alpidem (Ananxyl) 1995. Worldwide. Not approved in the US, withdrawn in France in 1994 [4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [3] [5] Alosetron (Lotronex) 2000. US. Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [2]
Amgen. non-small cell lung cancer with KRAS G12C mutation. Avapritinib. Blueprint Medicines Corp. granted for two indications: mast cell leukemia and advanced systemic mastocytosis. Belumosudil. Kadmon Pharmaceuticals. chronic graft-versus-host disease. Pembrolizumab.
Tsumura (ツムラ) is the leading maker [3] making 128 of the 148 kampo medicines. The "count" column shows in how many of these 128 formulae the herb is found. The most common herb is Glycyrrhizae Radix (Chinese liquorice root). It is in 94 of the 128 Tsumura formulae. Other common herbs are Zingiberis Rhizoma (ginger) (51 of 128 formulae ...